Barnes-Jewish Hospital — St Louis, Missouri

Public research footprint of Barnes-Jewish Hospital, compiled from the ClinicalTrials.gov public registry.

730

Registered studies

110

Active

Recruiting now

491

Completed

Stopped or withdrawn

Most-studied conditions

Hepatocellular Carcinoma · Rhabdomyosarcoma · Childhood Clear Cell Sarcoma of Soft Tissue · Recurrent Clear Cell Sarcoma of Soft Tissue

Recently updated registry entries

NCT02523014 — Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients… (Recruiting)
NCT03242642 — Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in… (Recruiting)
NCT02101788 — Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Barnes-Jewish Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.